TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivity
1
Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal, Quebec, Canada.
|
Publication type: Journal Article
Publication date: 1993-10-01
scimago Q1
wos Q1
SJR: 1.801
CiteScore: 11.5
Impact factor: 6.8
ISSN: 00222623, 15204804
PubMed ID:
8230106
Drug Discovery
Molecular Medicine
Abstract
Pseudopeptide analogues of the delta opioid antagonists H-Tyr-Tic-Phe-Phe-OH (TIPP) and H-Tyr-Tic-Phe-OH (TIP) containing a reduced peptide bond between the Tic2 and Phe3 residues were synthesized. The two compounds, H-Tyr-Tic psi [CH2NH]Phe-Phe-OH (TIPP [psi]) and H-Tyr-Tic psi-[CH2NH]Phe-OH (TIP [psi]), were tested in mu-, delta-, and kappa-receptor-selective binding assays and in the guinea pig ileum (GPI) and mouse vas deferens (MVD) bioassays. In comparison with their respective parent peptides, both pseudopeptide analogues showed increased delta antagonist potency in the MVD assay, higher delta receptor affinity and further improved delta receptor selectivity. The more potent compound, TIPP [psi], displayed subnanomolar delta receptor affinity and in direct comparisons with other selective delta ligands was shown to have unprecedented delta specificity (Ki mu/Ki delta = 10,500). Furthermore, this compound turned out to be highly stable against enzymatic degradation and, unlike other delta antagonists, showed no mu or kappa antagonist properties. TIPP [psi] is likely to find wide use as a pharmacological tool in opioid research.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
|
|
|
Journal of Medicinal Chemistry
14 publications, 11.2%
|
|
|
Journal of Pharmacology and Experimental Therapeutics
5 publications, 4%
|
|
|
Biopolymers
5 publications, 4%
|
|
|
Life Sciences
4 publications, 3.2%
|
|
|
British Journal of Pharmacology
4 publications, 3.2%
|
|
|
European Journal of Pharmacology
3 publications, 2.4%
|
|
|
Neuroscience
3 publications, 2.4%
|
|
|
Letters in Peptide Science
3 publications, 2.4%
|
|
|
Journal of Peptide Research
3 publications, 2.4%
|
|
|
Regulatory Peptides
2 publications, 1.6%
|
|
|
Bioorganic and Medicinal Chemistry Letters
2 publications, 1.6%
|
|
|
Neuropeptides
2 publications, 1.6%
|
|
|
Tetrahedron
2 publications, 1.6%
|
|
|
Tetrahedron Letters
2 publications, 1.6%
|
|
|
Peptides
2 publications, 1.6%
|
|
|
Amino Acids
2 publications, 1.6%
|
|
|
Neuron
2 publications, 1.6%
|
|
|
Current Protocols in Pharmacology
2 publications, 1.6%
|
|
|
Organic Letters
1 publication, 0.8%
|
|
|
Neuroscience Letters
1 publication, 0.8%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 0.8%
|
|
|
American Journal of Obstetrics and Gynecology
1 publication, 0.8%
|
|
|
Trends in Pharmacological Sciences
1 publication, 0.8%
|
|
|
Drug Discovery Today
1 publication, 0.8%
|
|
|
Progress in Neurobiology
1 publication, 0.8%
|
|
|
Pain Forum
1 publication, 0.8%
|
|
|
Pharmacological Reviews
1 publication, 0.8%
|
|
|
Environmental Health Perspectives
1 publication, 0.8%
|
|
|
Tetrahedron Asymmetry
1 publication, 0.8%
|
|
|
2
4
6
8
10
12
14
|
Publishers
|
5
10
15
20
25
30
35
40
45
50
|
|
|
Elsevier
46 publications, 36.8%
|
|
|
Wiley
21 publications, 16.8%
|
|
|
American Chemical Society (ACS)
16 publications, 12.8%
|
|
|
Springer Nature
10 publications, 8%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
4 publications, 3.2%
|
|
|
Taylor & Francis
2 publications, 1.6%
|
|
|
Environmental Health Perspectives
1 publication, 0.8%
|
|
|
S. Karger AG
1 publication, 0.8%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.8%
|
|
|
Pleiades Publishing
1 publication, 0.8%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.8%
|
|
|
Walter de Gruyter
1 publication, 0.8%
|
|
|
Institute of Physiology of the Czech Academy of Sciences
1 publication, 0.8%
|
|
|
American Physiological Society
1 publication, 0.8%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.8%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.8%
|
|
|
5
10
15
20
25
30
35
40
45
50
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
125
Total citations:
125
Citations from 2024:
1
(0.8%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Schiller P. et al. TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivity // Journal of Medicinal Chemistry. 1993. Vol. 36. No. 21. pp. 3182-3187.
GOST all authors (up to 50)
Copy
Schiller P. TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivity // Journal of Medicinal Chemistry. 1993. Vol. 36. No. 21. pp. 3182-3187.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/jm00073a020
UR - https://doi.org/10.1021/jm00073a020
TI - TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivity
T2 - Journal of Medicinal Chemistry
AU - Schiller, P.
PY - 1993
DA - 1993/10/01
PB - American Chemical Society (ACS)
SP - 3182-3187
IS - 21
VL - 36
PMID - 8230106
SN - 0022-2623
SN - 1520-4804
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{1993_Schiller,
author = {P. Schiller},
title = {TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivity},
journal = {Journal of Medicinal Chemistry},
year = {1993},
volume = {36},
publisher = {American Chemical Society (ACS)},
month = {oct},
url = {https://doi.org/10.1021/jm00073a020},
number = {21},
pages = {3182--3187},
doi = {10.1021/jm00073a020}
}
Cite this
MLA
Copy
Schiller, P., et al. “TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivity.” Journal of Medicinal Chemistry, vol. 36, no. 21, Oct. 1993, pp. 3182-3187. https://doi.org/10.1021/jm00073a020.